IHG Genotech Symposium October 16th, 2023 Agenda
| Time | Who | Title | Talk Title | |
| Introductions | 9:00-9:10 | Sam Hawgood | Chancellor, UCSF | |
| 9:10-9:15 | Introduction by Nadav Ahituv | Director, UCSF Institute for Human Genetics | ||
| Gene Therapy | 9:15-9:30 | Janice Chen | Co-Founder, Chief Technical Officer, Mammoth Biosciences | Deploying Ultracompact CRISPR Systems for in Vivo Gene Editing |
| 9:30-9:45 | Benjamin L. Oakes | Co-Founder, President and Chief Executive Officer, Scribe Therapeutics | Creation of the X-Editor Platform | |
| 9:45-10:00 | Lexi Rovner | Co-Founder, Chief Executive Officer, 64X Bio | Engineering Cell Lines for Enhanced Production of Next-Generation Therapeutics | |
| 10:00-10:15 | Navneet Matharu | Co-Founder, Chief Scientific Officer, Regel Therapeutics; Assistant Professor, UCSF | Technology to Therapy: Modulating Gene Regulation to Treat Diseases | |
| 10:15-10:45 | Panel Discussion | |||
| Coffee Break | 10:45-11:15 | |||
| Liquid Biopsy | 11:15-11:30 | Babak Alipanahi | Chief Scientific Officer and Co-founder, Exai Bio, Inc | Early Cancer Detection Using Orphan Noncoding RNAs |
| 11:30-11:45 | Darya Chudova | Chief Technology Officer, Guardant Health | Smart Liquid Biopsy - Enabling deeper Tumor Sensing and Wider Biological View with Epigenomics | |
| 11:45-12:00 | Jing Huang | Fellow of the American Statistical Association (FASA), SVP of Bioinformatics and Data Science at Veracyte Inc. | Using Genomic Features to Make Smart Clinical Decisions: The Power of Machine Learning with RNA-Seq | |
| 12:00-12:15 | Eric Collisson | Professor, Department of Medicine, UCSF | Preparing for Success. What Does “Acting” on Positive Early Detection Tests Actually Mean? | |
| 12:15-12:45 | Panel Discussion | |||
| Lunch & Career Panel | 12:45-1:45 | Trainee Lunch & Career Panel |
Peyton Greenside, Co-founder and Chief Scientific Officer, BigHat Biosciences John Marioni, Senior Vice President and Head of Computation, Genentech Navneet Matharu, Co-Founder, Chief Scientific Officer, Regel Therapeutics; Assistant Professor, UCSF Lexi Rovner, Co-Founder, Chief Executive Officer, 64X Bio |
|
| Keynote Speaker | 1:45-1:50 | Introduction by Adam Abate | Professor of Bioengineering and Therapeutic Sciences | |
| 1:50-2:30 | Stephen Quake | Lee Otterson Professor of Bioengineering and Applied Physics, Stanford University, and Head of Science, Chan Zuckerberg Initiative | Creating Health Equity with Liquid Biopsies | |
| Artificial Intelligence | 2:30-2:45 | Peyton Greenside | Co-founder and Chief Scientific Officer, BigHat Biosciences | Designing Therapeutic Antibodies with Synthetic Biology and Machine Learning |
| 2:45-3:00 | John Marioni | Senior Vice President and Head of Computation, Genentech | Beyond Atlases: New Computational Challenges in Single-Cell Genomics Data | |
| 3:00-3:15 | Vasilis Ntranos | Assistant Professor, Department of Epidemiology & Biostatistics | Genome-wide Prediction of Disease Variant Effects with Protein Language Models | |
| 3:15-3:45 | Panel Discussion | |||
| Coffee Break | 3:45-4:15 | |||
| Genomic Technologies | 4:15-4:30 | Ariel Jaimovich | Senior Director of R&D Integration, Ultima Genomics | Unleashing the Power of Genomics at Scale |
| 4:30-4:45 | Rob Tarbox | VP of Marketing, Complete Genomics | Enabling Multi-Omics, from Sub-Cellular Spatial Transcriptomics to WGS: Applications in Developmental, Neuro and Cancer Biology | |
| 4:45-5:00 | Michael Rhodes | Senior Director, Advanced Applications at Nanostring Technologies | Discover Spatial Multiomics: Single-Cell Imaging to High Plex Spatial Transcriptomics | |
| 5:00-5:15 | Ryan Corces | Assistant Professor, Neurology, UCSF, Assistant Investigator, Gladstone Institutes | Functional Dissection of Noncoding Disease Genetics | |
| 5:15-5:45 | Panel Discussion | |||
| Reception | 5:45 | |||
